B of A Securities Downgrades Omnicell to Neutral, Raises Price Target to $57
Omnicell, Inc. +2.26%
Omnicell, Inc. OMCL | 45.32 | +2.26% |
B of A Securities analyst Allen Lutz downgrades Omnicell (NASDAQ:
OMCL) from Buy to Neutral and raises the price target from $44 to $57.